This article needs additional citations for verification. (April 2020) |
Michael John Owen Wakelam (15 July 1955 – 31 March 2020) was a British molecular biologist and director of the Babraham Institute in Cambridge, England.
Michael Wakelam | |
|---|---|
| Born | 1955 |
| Died | 31 March 2020 |
| Nationality | British |
| Scientific career | |
| Fields | biochemistry, lipidomics, signal transduction |
| Institutions | Babraham Institute |
Biography edit
Wakelam received a BSc in medical biochemistry (1977) and a PhD in biochemistry (1980) from the University of Birmingham. After post-doctoral training at the University of Konstanz (DE), he joined the Department of Biochemistry of Imperial College London in 1983. In 1985, he joined the Biochemistry department of the University of Glasgow as a Lecturer (1985), Senior Lecturer (1991) and Reader (1992). He became a Professor of molecular pharmacology at the University of Birmingham in 1993. In 2007, he became director of the Babraham Institute in Cambridge.[1]
Wakelam died on 31 March 2020, of a suspected COVID-19 infection during the COVID-19 pandemic in England.[2]
References edit
- ^ "Michael Wakelam 1955 – 2020 | Babraham Institute". www.babraham.ac.uk. Retrieved 2 April 2020.
- ^ Babraham Institute director Professor Michael Wakelam dies after suspected coronavirus infection
External links edit
- Michael Wakelam's group Archived 17 June 2020 at the Wayback Machine at the Babraham Institute
 | This article about a biologist from the United Kingdom is a stub. You can help Wikipedia by expanding it. |